Radiko Holdings Corp. Aktie Canadian Securities Exchange
Aktien
A2QAAM
CA75034R1029
JUJU
Pharmazeutika
Umsatz 2018 | 106’584 145’119 96’569.37 | Umsatz 2019 | 5.18 Mio. 7.05 Mio. 4.69 Mio. | Marktwert | 6.17 Mio. 8.4 Mio. 5.59 Mio. |
---|---|---|---|---|---|
Nettoergebnis 2018 | -4 Mio. -5.45 Mio. -3.62 Mio. | Nettoergebnis 2019 | -10 Mio. -13.62 Mio. -9.06 Mio. | EV / Sales 2018 | 101 x |
Nettoschuld 2018 | 258’657 352’174 234’354 | Nettoschuld 2019 | 1.98 Mio. 2.7 Mio. 1.79 Mio. | EV / Sales 2019 | 1.57 x |
KGV 2018 |
-1.5
x | KGV 2019 |
-0.53
x | Beschäftigte | - |
Rendite 2018 * |
-
| Rendite 2019 |
-
| Streubesitz | 96.73% |
Manager | Titel | Alter | Seit |
---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 16.04.18 |
David Rosenberg
CTO | Chief Tech/Sci/R&D Officer | - | 10.12.19 |
Scott Reeves
BRD | Director/Board Member | 55 | 01.02.17 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 16.04.18 |
Scott Reeves
BRD | Director/Board Member | 55 | 01.02.17 |
Robert Yosaitis
BRD | Director/Board Member | - | 12.11.19 |
% 1. Jan. | Kap. | |
---|---|---|
+32.36% | 709 Mrd. | |
+30.77% | 595 Mrd. | |
-1.60% | 367 Mrd. | |
+20.07% | 334 Mrd. | |
+6.04% | 289 Mrd. | |
+14.77% | 239 Mrd. | |
+9.13% | 211 Mrd. | |
-3.97% | 203 Mrd. | |
+9.27% | 171 Mrd. |